Sangamo Therapeutics Inc.

NASDAQ: SGMO · Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT

Sangamo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
41.92M 45.2M 100.44M 178.87M
Short-Term Investments
n/a 35.8M 177.19M 197.68M
Long-Term Investments
1.5M 1.5M 29.84M 88.17M
Other Long-Term Assets
13.69M 16.63M 12.25M 10.17M
Receivables
4.6M 4.07M 4.47M 6.36M
Inventory
n/a n/a n/a -88.17M
Other Current Assets
5.17M 9.26M n/a 88.17M
Total Current Assets
51.69M 94.33M 300.33M 398.77M
Property-Plant & Equipment
34.76M 52.87M 125.53M 124.7M
Goodwill & Intangibles
n/a n/a 88.28M 93.46M
Total Long-Term Assets
49.94M 70.99M 262.18M 323.15M
Total Assets
101.64M 165.32M 562.51M 721.92M
Account Payables
15.48M 15.26M 22.42M 9.76M
Deferred Revenue
7.56M n/a 51.78M 85.71M
Short-Term Debt
n/a n/a n/a 4.03M
Other Current Liabilities
14.57M 11.73M 11.88M 3.52M
Total Current Liabilities
45.8M 47.73M 111.71M 127.89M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
933K 1.19M 1.21M 1.22M
Total Long-Term Liabilities
33.06M 34.7M 155.84M 218.69M
Total Liabilities
78.86M 82.43M 267.55M 346.58M
Total Debt
30.57M 38.1M 43.11M 48.08M
Common Stock
2.13M 1.78M 1.67M 1.46M
Retained Earnings
-1.5B -1.41B -1.15B -956.27M
Comprehensive Income
-7.53M -4.59M -8.4M -3.99M
Shareholders Equity
22.77M 82.89M 294.96M 375.34M
Total Investments
1.5M 35.8M 207.03M 285.85M